<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/78778E97-5A2E-40A6-A88F-137A343A3530"><gtr:id>78778E97-5A2E-40A6-A88F-137A343A3530</gtr:id><gtr:name>University of Toronto</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/A1382653-9660-42B5-8658-B7FBD06F5D06"><gtr:id>A1382653-9660-42B5-8658-B7FBD06F5D06</gtr:id><gtr:name>AstraZeneca plc</gtr:name><gtr:address><gtr:line1>2 Kingdom Street</gtr:line1><gtr:postCode>W2 6BD</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/AD4854E1-71AF-4687-93A9-5F05968D34DB"><gtr:id>AD4854E1-71AF-4687-93A9-5F05968D34DB</gtr:id><gtr:name>University of Pisa</gtr:name><gtr:address><gtr:line1>University of Pisa</gtr:line1><gtr:line2>Lungarno Pacinotti 43</gtr:line2><gtr:line4>Pisa</gtr:line4><gtr:postCode>I 56126</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Italy</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/AFBF2A7E-9CB1-4B05-A7C8-88903332FF09"><gtr:id>AFBF2A7E-9CB1-4B05-A7C8-88903332FF09</gtr:id><gtr:name>Cochin Institute</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/C3992259-C19F-4FE5-9C01-210C819D7264"><gtr:id>C3992259-C19F-4FE5-9C01-210C819D7264</gtr:id><gtr:name>Yale University</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:department>Dept of Chemistry</gtr:department><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/78778E97-5A2E-40A6-A88F-137A343A3530"><gtr:id>78778E97-5A2E-40A6-A88F-137A343A3530</gtr:id><gtr:name>University of Toronto</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/A1382653-9660-42B5-8658-B7FBD06F5D06"><gtr:id>A1382653-9660-42B5-8658-B7FBD06F5D06</gtr:id><gtr:name>AstraZeneca plc</gtr:name><gtr:address><gtr:line1>2 Kingdom Street</gtr:line1><gtr:postCode>W2 6BD</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/AD4854E1-71AF-4687-93A9-5F05968D34DB"><gtr:id>AD4854E1-71AF-4687-93A9-5F05968D34DB</gtr:id><gtr:name>University of Pisa</gtr:name><gtr:address><gtr:line1>University of Pisa</gtr:line1><gtr:line2>Lungarno Pacinotti 43</gtr:line2><gtr:line4>Pisa</gtr:line4><gtr:postCode>I 56126</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Italy</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/AFBF2A7E-9CB1-4B05-A7C8-88903332FF09"><gtr:id>AFBF2A7E-9CB1-4B05-A7C8-88903332FF09</gtr:id><gtr:name>Cochin Institute</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/C3992259-C19F-4FE5-9C01-210C819D7264"><gtr:id>C3992259-C19F-4FE5-9C01-210C819D7264</gtr:id><gtr:name>Yale University</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/37B9853E-9514-4E8D-A985-18621B05BD4B"><gtr:id>37B9853E-9514-4E8D-A985-18621B05BD4B</gtr:id><gtr:firstName>Isabelle</gtr:firstName><gtr:surname>Leclerc</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/CFAA70A9-58F6-4917-9260-A4338890F14F"><gtr:id>CFAA70A9-58F6-4917-9260-A4338890F14F</gtr:id><gtr:firstName>Guy</gtr:firstName><gtr:otherNames>Allen</gtr:otherNames><gtr:surname>Rutter</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/1953DE22-8CB4-4B20-87C0-58827CF7A586"><gtr:id>1953DE22-8CB4-4B20-87C0-58827CF7A586</gtr:id><gtr:firstName>Florence Susan</gtr:firstName><gtr:surname>Wong</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/D7E63F0C-8E0C-4D9E-A94F-92649DEAB8FA"><gtr:id>D7E63F0C-8E0C-4D9E-A94F-92649DEAB8FA</gtr:id><gtr:firstName>Richard</gtr:firstName><gtr:surname>Smith</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0401641"><gtr:id>03E09CBF-CD5B-4519-AD97-1757FFB8F9E2</gtr:id><gtr:title>Role of AMP-activated protein kinase in pancreatic islet beta-cell death during type 1 and type 2 diabetes</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0401641</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:technicalSummary>Diabetes mellitus currently affects ~ 5 % of the population in westernised societies, an incidence expected to double by 2020. Destruction of beta-cells, achieved respectively through immune-mediated attack or other mechanisms, is involved in the aetiology of type 1 and type 2 diabetes respectively. 
Our laboratories and others have demonstrated that AMP-activated protein kinase (AMPK) plays a key role in pancreatic islet beta-cells as a sensor of glucose. We propose here to explore the potential role of forced changes in AMPK activity, achieved using recombinant adenoviruses or transgenesis, in modulating beta-cell survival and function during a variety of pathophysiological pro-apoptotic assaults. Assessment of beta-cell function, necrosis and apoptosis will be achieved using a wide range of assays. Transplantation into mice of islets in which AMPK activity has been blocked or enhanced will also serve to assess the potential therapeutic value of these changes for human islet transplantation. Our principal aims are as follows:
Aim 1: The role of AMPK will be studied in three models relevant to beta cell death in type 1 diabetes:
(a) Non-immune attack in vitro: isolated mouse islets will be treated with the inflammatory cytokines, IL-1beta and TNFalpha 
(b) Immune-mediated destruction of islet beta-cells in vitro: islets isolated from non-obese diabetic (NOD) mice and incubated with insulin-reactive CD8+ T cells.
(c) Recurrent immune-mediated destruction of islet beta-cells in vivo. Syngeneic islets that have been infected with viral constructs (or null virus control) will be transplanted under the kidney capsule of diabetic NOD mice, and changes in glycaemia monitored as a read-out of beta-cell survival and function.
Aim 2: We propose to examine the role of AMPK in ex vivo models of beta cell failure, as follows:
(a)?Glucolipotoxicity? in vitro: achieved either over-expression of the lipogenic transcription factor, sterol regulatory element binding protein 1c (SREBP1c) or by treatment of MIN6 beta cells with high glucose and saturated fatty acid concentrations 
(b) Insulin or IGF-1 receptor depletion from cells. MIN6 cells will be deployed and receptor silencing achieved using specific, validated siRNAs
Aim 3: What mechanisms are involved in the execution of apoptosis during (a) pathophysiological stimulation (Aims 1 and 2) and (b) after activating AMPK? The role in both cases of downstream signalling pathways will be explored using classical biochemical approaches.
Aim 4: Generation and characterisation of transgenic mice expressing constitutively-active or dominant-negative AMPK selectively in pancreatic beta cells.</gtr:technicalSummary><gtr:fund><gtr:end>2010-04-03</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2006-04-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>956886</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>AstraZeneca</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Generator of b-cell specfic knock-out mice for PASK</gtr:description><gtr:id>323101CF-37D9-4EC9-9689-945A5C5F57DC</gtr:id><gtr:impact>None as yet</gtr:impact><gtr:piContribution>Design of PASK flox'd mice</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Cochin Institute (Institut Cochin)</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:description>Conditional knockout mice</gtr:description><gtr:id>010FAE45-BFE8-4DA4-8439-2F075CAE1071</gtr:id><gtr:impact>Publication in Diabetologia, 2010 (Sun et al)</gtr:impact><gtr:piContribution>Generation of tissue specifi KO mice</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Toronto</gtr:collaboratingOrganisation><gtr:country>Canada</gtr:country><gtr:description>AMPK in central control of hepatic glucose production</gtr:description><gtr:id>1994D4A7-068D-4191-A543-EE887C491A49</gtr:id><gtr:impact>Publication in Diabetes 2010 (x2)</gtr:impact><gtr:piContribution>Generation and use of adenoviral constructs</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Pisa (Universit? di Pisa)</gtr:collaboratingOrganisation><gtr:country>Italy, Italian Republic</gtr:country><gtr:description>Piero Marchetti (Pisa)</gtr:description><gtr:id>3D3D233A-757C-4D2D-8354-3D2D2486A584</gtr:id><gtr:impact>Sorcin links pancreatic ? cell lipotoxicity to ER Ca2+ stores - Marmugi A et al - PMID: 26822088
Hypoxia lowers SLC30A8/ZnT8 expression and free cytosolic Zn2+ in pancreatic beta cells. Gerber PA et al PMID: 24865615 
Incretin-modulated beta cell energetics in intact islets of Langerhans. Hodson DJ et al - PMID: 24766140 
ADCY5 couples glucose to insulin secretion in human islets. Hodson DJ et al PMID: 24740569 
Lipotoxicity disrupts incretin-regulated human ? cell connectivity. Hodson DJ et al - PMID: 24018562</gtr:impact><gtr:partnerContribution>experiments for publications</gtr:partnerContribution><gtr:piContribution>experiments for publications</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Yale University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Role of AMPK in counter regulation</gtr:description><gtr:id>798F3947-0CE6-498B-A21D-DDB757DFAA21</gtr:id><gtr:impact>None as yet</gtr:impact><gtr:piContribution>Provision of adenoviral constructs</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Talk to patient group (Twickenham, 2013)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>A417228C-8242-4E42-B6ED-C69AEFCE2B0D</gtr:id><gtr:impact>50 patients attended a research talk, which sparked questions and discussion afterwards

none</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Inaugural lecture - Imperial College</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>37A32562-0F71-45AA-9C1F-DEBC21946BFD</gtr:id><gtr:impact>Inaugural lecture: 'Regulating insulin secretion: can be correct the deficiency in type 2 diabetes

None measured.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Talk to patient group (Brentwood, 2014)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>52BCF7B1-559C-4069-A785-02C44DF5761C</gtr:id><gtr:impact>50 patients attended a research talk, which sparked questions and discussion afterwards

informed research</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>2200000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Imperial College Trust</gtr:department><gtr:description>MRC PRogramme</gtr:description><gtr:end>2019-05-02</gtr:end><gtr:fundingOrg>Imperial College London (ICL)</gtr:fundingOrg><gtr:fundingRef>MR/L02036X/1</gtr:fundingRef><gtr:id>6ACCC389-E376-4377-B5CC-DBF2BF55177A</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>470000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Seventh Framework Programme (FP7)</gtr:department><gtr:description>FP7</gtr:description><gtr:end>2015-09-02</gtr:end><gtr:fundingOrg>Community Research and Development Information Service (CORDIS)</gtr:fundingOrg><gtr:id>AD0D2025-6CCD-47F4-A1CB-30AA8670689C</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2010-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>622745</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Imperial College Trust</gtr:department><gtr:description>BBSRC</gtr:description><gtr:end>2015-10-02</gtr:end><gtr:fundingOrg>Imperial College London (ICL)</gtr:fundingOrg><gtr:fundingRef>BB/J015873/1</gtr:fundingRef><gtr:id>F9E8CE40-A927-46AE-9F2A-0447351E3D5B</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>500000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Programme Grant</gtr:description><gtr:end>2015-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>Role of NAADP and TPC proteins in stimulus-secretion coupling in pancreatic ?-cells</gtr:fundingRef><gtr:id>AD74FCD1-45E6-4ED0-BC63-7C70604F19C0</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2200000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Senior Investigator Award</gtr:description><gtr:end>2018-09-02</gtr:end><gtr:fundingOrg>The Wellcome Trust Ltd</gtr:fundingOrg><gtr:fundingRef>WT098424AIA</gtr:fundingRef><gtr:id>12C38E04-D828-467E-B532-6E9353AEEC53</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>3085359</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Imperial College Trust</gtr:department><gtr:description>MRC Experimental Challenge</gtr:description><gtr:end>2018-09-02</gtr:end><gtr:fundingOrg>Imperial College London (ICL)</gtr:fundingOrg><gtr:fundingRef>MR/L020149/1</gtr:fundingRef><gtr:id>748A4D16-5E2A-4659-B3FF-1939707DEA2B</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>482479</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Experimental Medicine Challenge Grant</gtr:department><gtr:description>Defining the molecular and physiological mechanisms of pancreatic islet dysfunction which lead to type 2 diabetes</gtr:description><gtr:end>2018-08-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/L020149/1</gtr:fundingRef><gtr:id>CC7EC403-7B16-4249-B5CC-CF0AB26893BE</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>50000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>ICL ISSF award</gtr:description><gtr:end>2014-09-02</gtr:end><gtr:fundingOrg>The Wellcome Trust Ltd</gtr:fundingOrg><gtr:id>C2FCA249-F1CC-4820-B759-D3E729EFCF8F</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>232543</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Diabetes UK</gtr:description><gtr:end>2016-02-02</gtr:end><gtr:fundingOrg>Diabetes UK</gtr:fundingOrg><gtr:fundingRef>BDA 12/0004535</gtr:fundingRef><gtr:id>52FE5D0A-4F37-4738-B1C3-F802EF710F7F</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1500000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Programme Grant</gtr:description><gtr:end>2017-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/J0003042/1</gtr:fundingRef><gtr:id>428CED5F-AD00-443B-9B83-AD123DA6BE86</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2200000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>MRC Programme Grant</gtr:department><gtr:description>Targeting etiological molecular mechanisms to treat human diabetes</gtr:description><gtr:end>2014-10-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/L02036X/1</gtr:fundingRef><gtr:id>B9FA39DE-BC01-4720-91ED-91EB22D95356</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2014-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>223220</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Diabetes UK</gtr:description><gtr:end>2014-09-02</gtr:end><gtr:fundingOrg>Diabetes UK</gtr:fundingOrg><gtr:fundingRef>BDA 11/004210</gtr:fundingRef><gtr:id>829E21CE-3616-436E-9487-14FBFE318F27</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Adenoviruses encoding active or dominant-negative AMPK</gtr:description><gtr:id>484B74D3-5532-4284-B33E-53976087A383</gtr:id><gtr:impact>Has allowed collaboration and studies of the role of AMPK in other tissues and systems (outside the pancreas).</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Adenoviruses</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/BD70C576-6711-4675-AFDF-503AD9ED2FE1"><gtr:id>BD70C576-6711-4675-AFDF-503AD9ED2FE1</gtr:id><gtr:title>Overexpression of monocarboxylate transporter-1 (SLC16A1) in mouse pancreatic ?-cells leads to relative hyperinsulinism during exercise.</gtr:title><gtr:parentPublicationTitle>Diabetes</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d261079c455ba41e062d7d7bd3aa6fe5"><gtr:id>d261079c455ba41e062d7d7bd3aa6fe5</gtr:id><gtr:otherNames>Pullen TJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0012-1797</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/EC559A61-6796-442C-A20E-F6BD1A10D0C0"><gtr:id>EC559A61-6796-442C-A20E-F6BD1A10D0C0</gtr:id><gtr:title>Insulin storage and glucose homeostasis in mice null for the granule zinc transporter ZnT8 and studies of the type 2 diabetes-associated variants.</gtr:title><gtr:parentPublicationTitle>Diabetes</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f23b79cb4073e941315deafe5a6b4d06"><gtr:id>f23b79cb4073e941315deafe5a6b4d06</gtr:id><gtr:otherNames>Nicolson TJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0012-1797</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A859DC4E-BFC7-4D0D-8CCE-1AD50746488D"><gtr:id>A859DC4E-BFC7-4D0D-8CCE-1AD50746488D</gtr:id><gtr:title>Human mutation within Per-Arnt-Sim (PAS) domain-containing protein kinase (PASK) causes basal insulin hypersecretion.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b3638fc82092488ecc480b6af0b9f6d8"><gtr:id>b3638fc82092488ecc480b6af0b9f6d8</gtr:id><gtr:otherNames>Semplici F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E4EE1225-59AD-4B6E-A51C-A1B2E1EEC4A9"><gtr:id>E4EE1225-59AD-4B6E-A51C-A1B2E1EEC4A9</gtr:id><gtr:title>The mitochondrial Ca2+ uniporter MCU is essential for glucose-induced ATP increases in pancreatic ?-cells.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b1104d53fe2bef61373ab4623ab8d6e5"><gtr:id>b1104d53fe2bef61373ab4623ab8d6e5</gtr:id><gtr:otherNames>Tarasov AI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2CBCCE44-141D-42DC-BF94-7634586DB6B5"><gtr:id>2CBCCE44-141D-42DC-BF94-7634586DB6B5</gtr:id><gtr:title>Inhibition of AMP-activated protein kinase protects pancreatic beta-cells from cytokine-mediated apoptosis and CD8+ T-cell-induced cytotoxicity.</gtr:title><gtr:parentPublicationTitle>Diabetes</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0e43b931d953cf1a82bf9aaf937d09a8"><gtr:id>0e43b931d953cf1a82bf9aaf937d09a8</gtr:id><gtr:otherNames>Riboulet-Chavey A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0012-1797</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A3722ADA-8B21-47ED-92FC-E01B77587F1A"><gtr:id>A3722ADA-8B21-47ED-92FC-E01B77587F1A</gtr:id><gtr:title>Calcium signalling-dependent mitochondrial dysfunction and bioenergetics regulation in respiratory chain Complex II deficiency.</gtr:title><gtr:parentPublicationTitle>Cell death and differentiation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/652d6ce5bb07efccc5fcd8bee36350b3"><gtr:id>652d6ce5bb07efccc5fcd8bee36350b3</gtr:id><gtr:otherNames>Mbaya E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1350-9047</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2D4547A2-BF48-4DC3-8143-0E8C80D1C877"><gtr:id>2D4547A2-BF48-4DC3-8143-0E8C80D1C877</gtr:id><gtr:title>Hypothalamic nutrient sensing activates a forebrain-hindbrain neuronal circuit to regulate glucose production in vivo.</gtr:title><gtr:parentPublicationTitle>Diabetes</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/811b3da259f99e1600b0c50f1d650ccd"><gtr:id>811b3da259f99e1600b0c50f1d650ccd</gtr:id><gtr:otherNames>Lam CK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0012-1797</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/157E7058-429F-4D4C-905B-4A74AF8703D0"><gtr:id>157E7058-429F-4D4C-905B-4A74AF8703D0</gtr:id><gtr:title>AMP-activated protein kinase regulates glucagon secretion from mouse pancreatic alpha cells.</gtr:title><gtr:parentPublicationTitle>Diabetologia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/803e68e336a2df90d51ab34ec4d1c99c"><gtr:id>803e68e336a2df90d51ab34ec4d1c99c</gtr:id><gtr:otherNames>Leclerc I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0012-186X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/82D4ABA1-A504-4C24-926F-FEB123D8A4B6"><gtr:id>82D4ABA1-A504-4C24-926F-FEB123D8A4B6</gtr:id><gtr:title>Cell-wide analysis of secretory granule dynamics in three dimensions in living pancreatic beta-cells: evidence against a role for AMPK-dependent phosphorylation of KLC1 at Ser517/Ser520 in glucose-stimulated insulin granule movement.</gtr:title><gtr:parentPublicationTitle>Biochemical Society transactions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d4e7055593b4cab4cb89842ebba2fb88"><gtr:id>d4e7055593b4cab4cb89842ebba2fb88</gtr:id><gtr:otherNames>McDonald A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0300-5127</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/29FA8147-A24B-4C2B-BC0D-E05FDDC63A37"><gtr:id>29FA8147-A24B-4C2B-BC0D-E05FDDC63A37</gtr:id><gtr:title>Ablation of AMP-activated protein kinase alpha1 and alpha2 from mouse pancreatic beta cells and RIP2.Cre neurons suppresses insulin release in vivo.</gtr:title><gtr:parentPublicationTitle>Diabetologia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/2c30fc7fc139ea2c7b5c5ae2c8e2ef60"><gtr:id>2c30fc7fc139ea2c7b5c5ae2c8e2ef60</gtr:id><gtr:otherNames>Sun G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0012-186X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D8852789-C716-49CD-8B66-EA3AB2B9B2E1"><gtr:id>D8852789-C716-49CD-8B66-EA3AB2B9B2E1</gtr:id><gtr:title>Nucleo-cytosolic shuttling of FoxO1 directly regulates mouse Ins2 but not Ins1 gene expression in pancreatic beta cells (MIN6).</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/407faeb2957ad2b98f5f836665657ed3"><gtr:id>407faeb2957ad2b98f5f836665657ed3</gtr:id><gtr:otherNames>Meur G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/88E59FA2-E038-4201-A8B5-172D42D97976"><gtr:id>88E59FA2-E038-4201-A8B5-172D42D97976</gtr:id><gtr:title>Class II phosphoinositide 3-kinase regulates exocytosis of insulin granules in pancreatic beta cells.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/10ff893d3afef61eceb2cbb039e65ea5"><gtr:id>10ff893d3afef61eceb2cbb039e65ea5</gtr:id><gtr:otherNames>Dominguez V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/CDBA049C-7DB8-4E0B-8F57-160BDC07CDEE"><gtr:id>CDBA049C-7DB8-4E0B-8F57-160BDC07CDEE</gtr:id><gtr:title>Identification of genes selectively disallowed in the pancreatic islet.</gtr:title><gtr:parentPublicationTitle>Islets</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d261079c455ba41e062d7d7bd3aa6fe5"><gtr:id>d261079c455ba41e062d7d7bd3aa6fe5</gtr:id><gtr:otherNames>Pullen TJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1938-2014</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/6C44AAB0-C5D0-4BEF-A6D3-BFF08C3A9F87"><gtr:id>6C44AAB0-C5D0-4BEF-A6D3-BFF08C3A9F87</gtr:id><gtr:title>Hypothalamic AMP-activated protein kinase regulates glucose production.</gtr:title><gtr:parentPublicationTitle>Diabetes</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/9c28acfbae39a4241f9743688f4d6af9"><gtr:id>9c28acfbae39a4241f9743688f4d6af9</gtr:id><gtr:otherNames>Yang CS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0012-1797</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2A585283-82AD-4D80-AD52-EEB0540B8284"><gtr:id>2A585283-82AD-4D80-AD52-EEB0540B8284</gtr:id><gtr:title>Genetically encoded FRET sensors to monitor intracellular Zn2+ homeostasis.</gtr:title><gtr:parentPublicationTitle>Nature methods</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/e386347dd00b6218b918163276726a65"><gtr:id>e386347dd00b6218b918163276726a65</gtr:id><gtr:otherNames>Vinkenborg JL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1548-7091</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/BFCA6ABE-DF4D-40F9-AF45-EF87C4F20829"><gtr:id>BFCA6ABE-DF4D-40F9-AF45-EF87C4F20829</gtr:id><gtr:title>Carbohydrate-responsive element-binding protein (ChREBP) is a negative regulator of ARNT/HIF-1beta gene expression in pancreatic islet beta-cells.</gtr:title><gtr:parentPublicationTitle>Diabetes</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/307bffb166e4801b69869d671f9b22e7"><gtr:id>307bffb166e4801b69869d671f9b22e7</gtr:id><gtr:otherNames>Noordeen NA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0012-1797</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C1D824E8-DA4C-4C51-85D9-0DE1D3A0D9B1"><gtr:id>C1D824E8-DA4C-4C51-85D9-0DE1D3A0D9B1</gtr:id><gtr:title>The AMP-regulated kinase family: enigmatic targets for diabetes therapy.</gtr:title><gtr:parentPublicationTitle>Molecular and cellular endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/683c3206afadea563aa753fcbd3ff3dc"><gtr:id>683c3206afadea563aa753fcbd3ff3dc</gtr:id><gtr:otherNames>Rutter GA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0303-7207</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/57282FA9-62CA-4714-A982-229327B9EC9C"><gtr:id>57282FA9-62CA-4714-A982-229327B9EC9C</gtr:id><gtr:title>Frequency-dependent mitochondrial Ca(2+) accumulation regulates ATP synthesis in pancreatic ? cells.</gtr:title><gtr:parentPublicationTitle>Pflugers Archiv : European journal of physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b1104d53fe2bef61373ab4623ab8d6e5"><gtr:id>b1104d53fe2bef61373ab4623ab8d6e5</gtr:id><gtr:otherNames>Tarasov AI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0031-6768</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/11A8A511-DC28-49DA-ACED-A441B6E8549B"><gtr:id>11A8A511-DC28-49DA-ACED-A441B6E8549B</gtr:id><gtr:title>The relationship between p38 mitogen-activated protein kinase and AMP-activated protein kinase during myocardial ischemia.</gtr:title><gtr:parentPublicationTitle>Cardiovascular research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a73d79ca53f79f1ea54870ad0371da3b"><gtr:id>a73d79ca53f79f1ea54870ad0371da3b</gtr:id><gtr:otherNames>Jacquet S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0008-6363</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2C4C3D31-617B-45AD-AF2A-CEB52A8B4D86"><gtr:id>2C4C3D31-617B-45AD-AF2A-CEB52A8B4D86</gtr:id><gtr:title>Regulation by Per-Arnt-Sim (PAS) kinase of pancreatic duodenal homeobox-1 nuclear import in pancreatic beta-cells.</gtr:title><gtr:parentPublicationTitle>Biochemical Society transactions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/af294e3765bfa3efcd513e5a1d78f164"><gtr:id>af294e3765bfa3efcd513e5a1d78f164</gtr:id><gtr:otherNames>An R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0300-5127</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/8635C617-1882-4C89-89B6-6EC7948084D6"><gtr:id>8635C617-1882-4C89-89B6-6EC7948084D6</gtr:id><gtr:title>An alternative polyadenylation signal in TCF7L2 generates isoforms that inhibit T cell factor/lymphoid-enhancer factor (TCF/LEF)-dependent target genes.</gtr:title><gtr:parentPublicationTitle>Diabetologia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8b9743f25761b017a70668cfab9b351c"><gtr:id>8b9743f25761b017a70668cfab9b351c</gtr:id><gtr:otherNames>Locke JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0012-186X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/EA8CE3EC-4388-4883-ADB0-78715C1E6C8A"><gtr:id>EA8CE3EC-4388-4883-ADB0-78715C1E6C8A</gtr:id><gtr:title>Over-expression of constitutively-activated or dominant-negative forms of AIMP-activated protein kinase (AMPK) selectively in the beta cells of transgenic mice exerts opposing effects on glucose tolerance</gtr:title><gtr:parentPublicationTitle>DIABETOLOGIA</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/926cc9d0088637a3b5e52ef05186dbb7"><gtr:id>926cc9d0088637a3b5e52ef05186dbb7</gtr:id><gtr:otherNames>Sun G.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0012-186X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/CD434EE8-83E4-459C-86C6-10737577992F"><gtr:id>CD434EE8-83E4-459C-86C6-10737577992F</gtr:id><gtr:title>Targeting the AMP-regulated kinase family to treat diabetes: a research update</gtr:title><gtr:parentPublicationTitle>Diabetes Management</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/2c30fc7fc139ea2c7b5c5ae2c8e2ef60"><gtr:id>2c30fc7fc139ea2c7b5c5ae2c8e2ef60</gtr:id><gtr:otherNames>Sun G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/BB6A9F8F-EC38-472A-BDEE-429B8FFF70F6"><gtr:id>BB6A9F8F-EC38-472A-BDEE-429B8FFF70F6</gtr:id><gtr:title>ChREBP regulates Pdx-1 and other glucose-sensitive genes in pancreatic ?-cells.</gtr:title><gtr:parentPublicationTitle>Biochemical and biophysical research communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f817dce2c86b25c911dd61faa4b09d11"><gtr:id>f817dce2c86b25c911dd61faa4b09d11</gtr:id><gtr:otherNames>da Silva Xavier G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0006-291X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/FC5B439C-7763-4784-AC56-CAE8B5E87636"><gtr:id>FC5B439C-7763-4784-AC56-CAE8B5E87636</gtr:id><gtr:title>LKB1 deletion with the RIP2.Cre transgene modifies pancreatic beta-cell morphology and enhances insulin secretion in vivo.</gtr:title><gtr:parentPublicationTitle>American journal of physiology. Endocrinology and metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/2c30fc7fc139ea2c7b5c5ae2c8e2ef60"><gtr:id>2c30fc7fc139ea2c7b5c5ae2c8e2ef60</gtr:id><gtr:otherNames>Sun G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0193-1849</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/38B1259E-F45E-48F3-AC9D-98FAF730158F"><gtr:id>38B1259E-F45E-48F3-AC9D-98FAF730158F</gtr:id><gtr:title>Phosphorylation by Per-Arnt-Sim (PAS) kinase may lead to nuclear exclusion and transcriptional repression of pancreatic duodenum homeobox-1 (PDX-1)</gtr:title><gtr:parentPublicationTitle>DIABETIC MEDICINE</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a7978e18c8234b77c83f65dddd17d4fb"><gtr:id>a7978e18c8234b77c83f65dddd17d4fb</gtr:id><gtr:otherNames>An R.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0742-3071</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/DE8B9954-0A04-4A25-9814-EBD2B70CF589"><gtr:id>DE8B9954-0A04-4A25-9814-EBD2B70CF589</gtr:id><gtr:title>Role of AMP-activated protein kinase in glucagon secretion</gtr:title><gtr:parentPublicationTitle>DIABETIC MEDICINE</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/580c54d68a4f749cdf99a26e3aabcfec"><gtr:id>580c54d68a4f749cdf99a26e3aabcfec</gtr:id><gtr:otherNames>Leclerc I.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0742-3071</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/426B5ABA-8766-4F39-B644-468E2E28DC04"><gtr:id>426B5ABA-8766-4F39-B644-468E2E28DC04</gtr:id><gtr:title>Pancreatic and duodenal homeobox 1 (PDX1) phosphorylation at serine-269 is HIPK2-dependent and affects PDX1 subnuclear localization.</gtr:title><gtr:parentPublicationTitle>Biochemical and biophysical research communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/af294e3765bfa3efcd513e5a1d78f164"><gtr:id>af294e3765bfa3efcd513e5a1d78f164</gtr:id><gtr:otherNames>An R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0006-291X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A92C5B8B-609B-4359-8E78-893CA2430714"><gtr:id>A92C5B8B-609B-4359-8E78-893CA2430714</gtr:id><gtr:title>Control of insulin granule dynamics by AMPK dependent KLC1 phosphorylation.</gtr:title><gtr:parentPublicationTitle>Islets</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d4e7055593b4cab4cb89842ebba2fb88"><gtr:id>d4e7055593b4cab4cb89842ebba2fb88</gtr:id><gtr:otherNames>McDonald A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1938-2014</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A06AE055-8AAE-4AED-BC2A-8B16BC1DCE9A"><gtr:id>A06AE055-8AAE-4AED-BC2A-8B16BC1DCE9A</gtr:id><gtr:title>Glucose-induced nuclear shuttling of ChREBP is mediated by sorcin and Ca(2+) ions in pancreatic ?-cells.</gtr:title><gtr:parentPublicationTitle>Diabetes</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/307bffb166e4801b69869d671f9b22e7"><gtr:id>307bffb166e4801b69869d671f9b22e7</gtr:id><gtr:otherNames>Noordeen NA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0012-1797</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/8A6986A8-F1E2-4898-9BDA-90DD06A412BF"><gtr:id>8A6986A8-F1E2-4898-9BDA-90DD06A412BF</gtr:id><gtr:title>The AMP-regulated kinase family: enigmatic targets for diabetes therapy.</gtr:title><gtr:parentPublicationTitle>Molecular and cellular endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/683c3206afadea563aa753fcbd3ff3dc"><gtr:id>683c3206afadea563aa753fcbd3ff3dc</gtr:id><gtr:otherNames>Rutter GA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0303-7207</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0B4403F6-4FD1-4947-BF37-833BD8FA4882"><gtr:id>0B4403F6-4FD1-4947-BF37-833BD8FA4882</gtr:id><gtr:title>Glucose-dependent regulation of gamma-aminobutyric acid (GABA A) receptor expression in mouse pancreatic islet alpha-cells.</gtr:title><gtr:parentPublicationTitle>Diabetes</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/60a4a7bc06824503fae0872c4f7d5db8"><gtr:id>60a4a7bc06824503fae0872c4f7d5db8</gtr:id><gtr:otherNames>Bailey SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0012-1797</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/DF528D35-DDC0-4DEA-BA7F-7E56529750AC"><gtr:id>DF528D35-DDC0-4DEA-BA7F-7E56529750AC</gtr:id><gtr:title>Insulin gene mutations resulting in early-onset diabetes: marked differences in clinical presentation, metabolic status, and pathogenic effect through endoplasmic reticulum retention.</gtr:title><gtr:parentPublicationTitle>Diabetes</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/407faeb2957ad2b98f5f836665657ed3"><gtr:id>407faeb2957ad2b98f5f836665657ed3</gtr:id><gtr:otherNames>Meur G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0012-1797</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3A7B2E25-8D72-4EB9-A781-A04E3519377B"><gtr:id>3A7B2E25-8D72-4EB9-A781-A04E3519377B</gtr:id><gtr:title>Inhibition of AMP-activated protein kinase protects pancreatic beta-cells from cytokine-mediated apoptosis and CD8+ T-cell-induced cytotoxicity.</gtr:title><gtr:parentPublicationTitle>Diabetes</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0e43b931d953cf1a82bf9aaf937d09a8"><gtr:id>0e43b931d953cf1a82bf9aaf937d09a8</gtr:id><gtr:otherNames>Riboulet-Chavey A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0012-1797</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/6E405D17-CD2C-40AA-81E7-CE5F8653D2F3"><gtr:id>6E405D17-CD2C-40AA-81E7-CE5F8653D2F3</gtr:id><gtr:title>A role for the CREB co-activator CRTC2 in the hypothalamic mechanisms linking glucose sensing with gene regulation.</gtr:title><gtr:parentPublicationTitle>EMBO reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ca4543aa88981d7f347fc8a752498bec"><gtr:id>ca4543aa88981d7f347fc8a752498bec</gtr:id><gtr:otherNames>Lerner RG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1469-221X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0E0DF384-A20F-43A2-B1C0-F1F1E56902F4"><gtr:id>0E0DF384-A20F-43A2-B1C0-F1F1E56902F4</gtr:id><gtr:title>Hypothalamic AMP-activated protein kinase regulates glucose production.</gtr:title><gtr:parentPublicationTitle>Diabetes</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/9c28acfbae39a4241f9743688f4d6af9"><gtr:id>9c28acfbae39a4241f9743688f4d6af9</gtr:id><gtr:otherNames>Yang CS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0012-1797</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/73C1ED7A-9AC6-4A4D-84CC-2BE36CA1C0E2"><gtr:id>73C1ED7A-9AC6-4A4D-84CC-2BE36CA1C0E2</gtr:id><gtr:title>PPAR?/d affects pancreatic ? cell mass and insulin secretion in mice.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical investigation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6269e13400a3fa521612633875db0f75"><gtr:id>6269e13400a3fa521612633875db0f75</gtr:id><gtr:otherNames>Iglesias J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0021-9738</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/56AA70CE-5295-496C-A6C4-6B8B35919B14"><gtr:id>56AA70CE-5295-496C-A6C4-6B8B35919B14</gtr:id><gtr:title>Abnormal glucose tolerance and insulin secretion in pancreas-specific Tcf7l2-null mice.</gtr:title><gtr:parentPublicationTitle>Diabetologia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f817dce2c86b25c911dd61faa4b09d11"><gtr:id>f817dce2c86b25c911dd61faa4b09d11</gtr:id><gtr:otherNames>da Silva Xavier G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0012-186X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/6EEE70BC-655F-4D1B-A8D4-DFE9DB32E49D"><gtr:id>6EEE70BC-655F-4D1B-A8D4-DFE9DB32E49D</gtr:id><gtr:title>Beta cell-specific Znt8 deletion in mice causes marked defects in insulin processing, crystallisation and secretion.</gtr:title><gtr:parentPublicationTitle>Diabetologia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/31089018c352bebbe1286d8b2cd165e8"><gtr:id>31089018c352bebbe1286d8b2cd165e8</gtr:id><gtr:otherNames>Wijesekara N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0012-186X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/03DB93ED-94F6-46FF-8819-852AF323EAFB"><gtr:id>03DB93ED-94F6-46FF-8819-852AF323EAFB</gtr:id><gtr:title>Per-arnt-sim (PAS) domain-containing protein kinase is downregulated in human islets in type 2 diabetes and regulates glucagon secretion.</gtr:title><gtr:parentPublicationTitle>Diabetologia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f817dce2c86b25c911dd61faa4b09d11"><gtr:id>f817dce2c86b25c911dd61faa4b09d11</gtr:id><gtr:otherNames>da Silva Xavier G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0012-186X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1F8B6763-9CA2-44C5-9EC1-02D73ECC9FFA"><gtr:id>1F8B6763-9CA2-44C5-9EC1-02D73ECC9FFA</gtr:id><gtr:title>Overexpression of ZAC impairs glucose-stimulated insulin translation and secretion in clonal pancreatic beta-cells.</gtr:title><gtr:parentPublicationTitle>Diabetes/metabolism research and reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/e165f1ee11aeb3c66375c0d54f55362e"><gtr:id>e165f1ee11aeb3c66375c0d54f55362e</gtr:id><gtr:otherNames>Du X</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1520-7552</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/706A402B-A2B4-45E6-B1A2-F7F574615BF6"><gtr:id>706A402B-A2B4-45E6-B1A2-F7F574615BF6</gtr:id><gtr:title>SREBP1 is required for the induction by glucose of pancreatic beta-cell genes involved in glucose sensing.</gtr:title><gtr:parentPublicationTitle>Journal of lipid research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3a6b57cc1b8f2d1d924ac7909df3268c"><gtr:id>3a6b57cc1b8f2d1d924ac7909df3268c</gtr:id><gtr:otherNames>Diraison F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-2275</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F534348D-FBC8-45DF-B3A7-22DF903F0FA6"><gtr:id>F534348D-FBC8-45DF-B3A7-22DF903F0FA6</gtr:id><gtr:title>LKB1 and AMPK regulate glucagon secretion in pancreatic a-cells to modulate whole body glucose metabolism</gtr:title><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/eb49ae58681b82fcdbd9d8e05a3dac86"><gtr:id>eb49ae58681b82fcdbd9d8e05a3dac86</gtr:id><gtr:otherNames>Sun, G</gtr:otherNames></gtr:author></gtr:authors></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/59CD9BD0-124D-47AE-9225-CDD2F6B96EF1"><gtr:id>59CD9BD0-124D-47AE-9225-CDD2F6B96EF1</gtr:id><gtr:title>Dynamic changes in cytosolic and mitochondrial ATP levels in pancreatic acinar cells.</gtr:title><gtr:parentPublicationTitle>Gastroenterology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ee041eaad947038b2a1e7cff217e309c"><gtr:id>ee041eaad947038b2a1e7cff217e309c</gtr:id><gtr:otherNames>Voronina SG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0016-5085</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/88F590C1-DEC6-4426-A5B4-C00F6C279CBD"><gtr:id>88F590C1-DEC6-4426-A5B4-C00F6C279CBD</gtr:id><gtr:title>Glucose regulates free cytosolic Zn&amp;sup2;? concentration, Slc39 (ZiP), and metallothionein gene expression in primary pancreatic islet ?-cells.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6b8a0c691ba5a9e1537eb6624cba3a5d"><gtr:id>6b8a0c691ba5a9e1537eb6624cba3a5d</gtr:id><gtr:otherNames>Bellomo EA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F2093249-1141-4127-BA35-7613E316A616"><gtr:id>F2093249-1141-4127-BA35-7613E316A616</gtr:id><gtr:title>TCF7L2 regulates late events in insulin secretion from pancreatic islet beta-cells.</gtr:title><gtr:parentPublicationTitle>Diabetes</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f817dce2c86b25c911dd61faa4b09d11"><gtr:id>f817dce2c86b25c911dd61faa4b09d11</gtr:id><gtr:otherNames>da Silva Xavier G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0012-1797</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3E7BCDE1-BF68-4359-9D15-35BD38ED6EE6"><gtr:id>3E7BCDE1-BF68-4359-9D15-35BD38ED6EE6</gtr:id><gtr:title>Regulating glucagon secretion: somatostatin in the spotlight.</gtr:title><gtr:parentPublicationTitle>Diabetes</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/683c3206afadea563aa753fcbd3ff3dc"><gtr:id>683c3206afadea563aa753fcbd3ff3dc</gtr:id><gtr:otherNames>Rutter GA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0012-1797</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4C8A37BA-1CE6-4E2E-BC1B-80BB6716DD9F"><gtr:id>4C8A37BA-1CE6-4E2E-BC1B-80BB6716DD9F</gtr:id><gtr:title>miR-29a and miR-29b contribute to pancreatic beta-cell-specific silencing of monocarboxylate transporter 1 (Mct1).</gtr:title><gtr:parentPublicationTitle>Molecular and cellular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d261079c455ba41e062d7d7bd3aa6fe5"><gtr:id>d261079c455ba41e062d7d7bd3aa6fe5</gtr:id><gtr:otherNames>Pullen TJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0270-7306</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/004DABE3-7431-4D9D-8850-4C022F0E13D5"><gtr:id>004DABE3-7431-4D9D-8850-4C022F0E13D5</gtr:id><gtr:title>RIP2-mediated LKB1 deletion causes axon degeneration in the spinal cord and hind-limb paralysis.</gtr:title><gtr:parentPublicationTitle>Disease models &amp; mechanisms</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/2c30fc7fc139ea2c7b5c5ae2c8e2ef60"><gtr:id>2c30fc7fc139ea2c7b5c5ae2c8e2ef60</gtr:id><gtr:otherNames>Sun G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1754-8403</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0401641</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>160D22D0-5677-4513-A0AC-7F3526B7F336</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Metabolic and Endocrine</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>